Diabetes Pro Quarterly - Winter 2020 - 17

80th Scientific Sessions News
continued from previous page
Noon to 1:00 p.m.

»	New Insights from the

Restoring Insulin Secretion
(RISE) Study-Differences
Between Adults and Youth
with Prediabetes and Type 2
Diabetes
»	Professional Interest Group
Discussion on Diabetes &
Cardiovascular Disease
»	Professional Interest Group
Discussion on Eye Health
»	Professional Interest Group
Discussion on Behavioral
Medicine & Psychology-
The Value Proposition for
Behavioral Health- Examples
of Effectively Making the Case
»	Professional Interest Group
Discussion on Diabetes
Self-Management Education
& Support (DSMES)-Focus
on 2020 DSMES Consensus
Report
»	Women's Interprofessional
Network of the ADA (WIN
ADA) Discussion- Finding
Equilibrium-Rethinking
"Work-Life Balance" to
Maintain Personal Wellness
»	Professional Interest Group
Discussion on Diabetes in
Youth-"Do-It-Yourself"/"DoIt-Together" (DIY-DIT) ClosedLoop Systems in Youth
Noon to 1:00 p.m.

»	General Poster Session/

Moderated Poster Discussions/
ePoster Theater Sessions

1:00 to 2:00 p.m.

»	Session Break (Take this

opportunity to visit the Exhibit
and Poster Halls)

2:15 to 4:15 p.m.

»	Update on Lipid-Lowering
Drugs

»	New Perspectives on Diabetic

Retinopathy Diagnosis and
Treatment
»	Reaching the Hard to Reach-
Real-World Stories
»	Strength-Based Approaches
in Diabetes Care-Challenging
the Deficit Model
»	Low-Carb Diets in Pediatric
Type 1 Diabetes-Pros and
Cons
»	Low-Carb Diets in Pediatric
Type 1 Diabetes-Yes or No?
»	Kelly West Award for
Outstanding Achievement in
Epidemiology Lecture
»	Joint ADA/Diabetes
UK Symposium-Islet
Transplantation-Quo Vadis?

»	Not Your Grandmother's

Transcription Factors-
New Insights into Genomic
Regulation of β-Cell Function
»	Oral Presentations
4:30 to 6:30 p.m.

»	Joint ADA/ASN Symposium-

Targeting Diabetic Kidney
Disease-Are We Ready for
Precision Medicine Trials?
»	Debate-Reconciling
Guideline Recommendations
for Cardiovascular Risk and
Disease Management in Type
2 Diabetes
»	Roger Pecoraro Award Lecture
»	What Will Be the Impact
of Proposed Health Policy
Changes on Diabetes Care?
»	Menopause and Diabetes
»	Population Health Efforts in the
Prevention and Treatment of
Diabetes
»	Nonalcoholic Steatohepatitis-
Emerging Concepts and
Opportunities
»	Physiological Mechanisms of
Remission of Type 2 Diabetes
»	Oral Presentations

Monday, June 15
7:30 a.m. to 4:00 p.m.

»	Registration Open
»	Poster Hall Open (to 2:00 p.m.)
»	Shop Diabetes Store Open
(to 6:45 p.m.)

8:00 to 10:00 a.m.

»	Addressing Care Gaps-New

Frontiers for Diabetes Nutrition
Providers and Services
»	Utilizing Diabetes Technology
in the Real World-Tools of the
Trade
»	How Do GLP-1 Receptor
Agonists Provide
Cardioprotection?
»	Joint ADA/AACC
Symposium-Point-of-Care
HbA1c-Should We Use It to
Diagnose Diabetes?
»	Update from the TEDDY Study
»	From Genome-Wide
Association Studies to Multiomics-Defining Diabetes Risk
and Clinical Relevance
»	Leveraging Metabolism to
Prevent, Treat, or Cure Type 1
Diabetes
»	Trouble in the Neighborhood-
Endocrine/Exocrine
Interactions in Diabetes
»	Oral Presentations
10:00 a.m. to 4:00 p.m.

»	Exhibit Hall Open

Information subject to change.

»	The Human Pancreas in Type 1

10:10 to 11:45 a.m.

»	National Scientific & Health

Diabetes

»	Inter-Organ Cross Talk in

Care Achievement Awards
Presentation and Outstanding
Scientific Achievement Award
Lecture

Physiology and Metabolic
Disease
»	Oral Presentations

Noon to 1:00 p.m.

4:30 to 6:30 p.m.

»	Professional Interest Group

»	Novel Approaches for Cell and

Discussion on Diabetes
Technology-Interpreting
Time-in-Range in Different
Populations and Situations
»	Professional Interest Group
Discussion on Health
Care Delivery & Quality
Improvement-Leveraging
Population Health Methods to
Improve Diabetes Care
»	Professional Interest Group
Discussion on Pregnancy
& Reproductive Health-
All Pregnant Women with
Preexisting Diabetes Should
Take Low-Dose Aspirin to
Prevent Preeclampsia
»	Professional Interest Group
Discussion on Public Health &
Epidemiology-Diabetes and
Built Environment
»	Professional Interest Group
Discussion on Immunology,
Immunogenetics, &
Transplantation

Tissue Interrogation-Using
the Kidney as a Model
»	Interpreting Cardiovascular
Outcomes Trials-Implications
for Practice
»	The Year in Review-Highlights
of the Past Year in Basic,
Translational, and Clinical
Science
»	Perspectives on the Future
of Precision Diabetes
Medicine-A Joint ADA/EASD
Symposium
»	Cognitive Function in Obesity
and Appetite Regulation
»	It's All in the Timing-Time and
Age-Related Changes in Islet
Function
»	Oral Presentations

Tuesday, June 16
7:30 to 10:30 a.m.

»	Registration Open
»	Shop Diabetes Store Open

Noon to 1:00 p.m.

(to 12:30 p.m.)

»	General Poster Session/

Moderated Poster Discussions/
ePoster Theater Sessions

1:00 to 2:00 p.m.

»	Session Break (Take this

opportunity to visit the Exhibit
and Poster Halls)

2:15 to 4:15 p.m.

»	Hypoglycemia-All about the
Brain

»	Disparities in Diabetes and

Diabetes Care-What Can We
Do about It?
»	Physical Activity and
Diabetes-When, How Much,
Insulin Adjustments, and More
»	Debate-Primary
Cardiovascular Prevention with
SGLT2 Inhibitors or GLP-1
Receptor Agonists-Are We
Ready for Prime Time?
»	Weekly Basal Insulin-The
Wave of the Future?
»	Artificial Intelligence, Machine
Learning, and Diabetes
»	Fetal Sex and Pregnancy
Outcomes
»	Twenty Years of Pediatric
Diabetes Surveillance-What
Do We Know and Why It
Matters-The SEARCH for
Diabetes in Youth Study

8:00 to 10:00 a.m.

»	Debate-Microvascular and

Macrovascular Complications
of Diabetes Are Distinct
Pathophysiologic Entities
»	Debate-Drawing the
Line between Primary and
Secondary Prevention-
Necessary or Too Simplistic?
»	Diabetes Meets the
Sandman-Sleep, Diabetes,
and Glycemic Management
»	SGLT2 Inhibitors-How Do
They Reduce Cardiorenal
Disease?
»	New Data from the Diabetes
Prevention Program Outcomes
Study (DPPOS)
»	Immune Intervention During
the Stages of Type 1 Diabetes
Development-Type 1
Diabetes TrialNet
»	Economic Drivers of Obesity
Treatment-From Individuals
to Systems
»	What's New with GLP-1?
10:15 a.m. to 12:15 p.m.

»	Results of the eValuation

of ERTugliflozin EffIcacy
and Safety CardioVascular
Outcomes Trial (VERTIS-CV)

professional.diabetes.org

17
http://professional.diabetes.org
Diabetes Pro Quarterly - Winter 2020

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Winter 2020
